Dr. E. Fiona Bailey's lab at the University of Arizona focuses on innovative exercise interventions to improve cardiovascular health, particularly in older adults suffering from sleep-disordered breathing. Their research highlights the effectiveness of a brief, targeted inspiratory muscle strength training (IMST) regimen that shows promise in reducing blood pressure and enhancing vascular function. This work aims to provide practical solutions to manage hypertension in populations unable to engage in traditional exercise due to health challenges.

Dr. Jennifer Kehlet Barton's research lab at the University of Arizona focuses on understanding and improving women's reproductive health. The lab studies the vital role of motile cilia in the fallopian tubes, which are critical for fertility, and seeks to develop advanced imaging techniques for clinical applications. Additionally, the lab aims to enhance early detection methods for ovarian cancer by combining blood biomarkers and innovative imaging technologies.

Dr. Gregory Charles Rogers' research lab at the University of Arizona focuses on understanding the structure and function of centrosomes, which are essential organelles in cells that organize microtubules. The lab investigates how centrioles, the core components of centrosomes, duplicate and elongate, and how this process is regulated. This work is crucial as misregulated centriole duplication can lead to serious health issues such as birth defects and cancer.

Dr. Gregory R. J. Thatcher's lab at the University of Arizona focuses on understanding how certain genetic factors and metabolic diseases, like type 2 diabetes and Alzheimer's disease, are interconnected. They aim to develop new drugs that can treat Alzheimer's by enhancing cholesterol metabolism without causing weight gain or other side effects. The lab uses a variety of animal models to test these potential treatments and investigate their effects on brain health.

Dr. Carol A. Barnes leads a research lab at the University of Arizona focusing on understanding how aging affects cognitive function and memory. The lab investigates the biological underpinnings of cognitive decline in older adults and explores ways to enhance brain health through precision medicine. By utilizing advanced experimental techniques in animal models and imaging technologies in humans, the lab aims to improve our understanding of age-related cognitive impairments and develop personalized interventions for conditions like Alzheimer’s disease.

Dr. Tally Marie Milnes' research lab at the University of Arizona focuses on understanding how the endocannabinoid system can be targeted to treat conditions related to opioid use and headaches. The lab explores innovative approaches to investigating opioid-induced respiratory depression and migraine symptoms, combining techniques from pharmacology and molecular biology. Their work aims to develop new therapeutic strategies that could enhance current treatments for pain and opioid overdose management.

Dr. Roberta Brinton's lab at the University of Arizona focuses on understanding how estrogen affects brain health, particularly during the transition to menopause. The research investigates the impact of aging and hormonal changes on the brain's energy systems and their implications for diseases like Alzheimer's. By studying these mechanisms, the lab aims to find ways to prevent or delay cognitive decline in aging women due to hormonal changes.

Dr. Lars R. Furenlid's lab focuses on innovative imaging technologies to improve brain imaging for medical research and diagnostics. They are developing a new hybrid imaging system that combines gamma-ray and positron emission imaging to visualize brain structures at high resolution. This technology could enhance our understanding of brain function and disorders by allowing detailed imaging of how radiotracers interact in the brain.

Dr. Henk Granzier's lab at the University of Arizona focuses on the giant protein titin and its role in muscle function and stiffness regulation. They investigate how titin interacts with muscle filaments during contraction and how mutations in this protein can lead to muscle diseases. By using mouse models and various experimental techniques, the lab aims to deepen our understanding of muscle mechanics, which could pave the way for new therapies for muscle-related conditions.

Dr. Meredith Hay's research lab focuses on developing new treatments for cognitive impairment, particularly in patients at risk for vascular dementia and Alzheimer's disease. The lab is working on a peptide called PNA5, which has shown promise in reducing inflammation and improving brain blood flow to restore cognitive function. Through various studies, they aim to prepare PNA5 for clinical trials that could lead to new therapies for these debilitating conditions.

Srinivasan Vedantham's lab at the University of Arizona focuses on developing and optimizing a specialized imaging technology called dedicated breast CT. This innovative method aims to provide high-resolution, 3D images of the breast without the need for physical compression, which has been a limitation of traditional mammography. The lab's ongoing research includes enhancing image reconstruction techniques and comparing the performance of breast CT against the standard digital breast tomosynthesis for more effective breast cancer screening.

Dr. Hongmin Li's lab focuses on developing new antiviral drugs specifically targeting flaviviruses, which are viruses transmitted by insects like mosquitoes and are known to cause serious illnesses in humans. The lab investigates essential viral enzymes to find compounds that can inhibit the viruses' ability to replicate and evade the immune system. Through advanced techniques in medicinal chemistry and biochemistry, the lab aims to create effective treatments for infections such as dengue and Japanese encephalitis.

Dr. Mingyu Liang's lab at the University of Arizona focuses on understanding the genetic and epigenetic factors behind chronic kidney disease. They are developing a unique set of human stem cell models to investigate how specific genetic variations influence kidney function. This research aims to create valuable resources for scientists studying kidney disease and to help develop targeted therapies.

Dr. Julie Gunnells Ledford’s lab at the University of Arizona focuses on understanding how a protein called CC16 influences lung health, especially in the context of asthma and chronic obstructive pulmonary disease (COPD). The research aims to uncover how CC16 helps defend against respiratory infections and how deficiencies in this protein during early life can affect long-term lung function. The lab investigates both the immune response to viruses like Rhinovirus and how early life infections can lead to changes in lung development and disease progression.

Dr. Luciano Matzkin's lab at the University of Arizona explores the role of male ejaculate RNA in fertility and reproductive processes. The lab primarily studies how RNA transferred from males during mating affects female reproductive responses, leveraging innovative techniques to understand these complex interactions. This research has important implications for understanding fertility in various species, including humans, and could lead to new treatments for infertility.

Dr. Jeannie Kim Lee's lab at the University of Arizona focuses on improving medication adherence in diverse populations with hypertension. The lab employs a team of clinical pharmacists and community health workers to provide personalized support for patients, addressing cultural and structural barriers to care. Their research aims to develop and test innovative intervention strategies to reduce health disparities, especially in African-American, Latino, and Vietnamese immigrant communities.

Dr. Frank Porreca's research lab focuses on understanding the brain circuits involved in migraine pain, a common and debilitating condition. The lab investigates how specific pathways and neuron types contribute to pain perception during migraine attacks, aiming to develop better treatments for patients who do not respond adequately to existing therapies. Through various advanced techniques, the lab explores both the genetic and physiological aspects of migraine to uncover new therapeutic targets.

Dr. Xinxin Ding's lab at the University of Arizona studies the harmful effects of naphthalene, a common pollutant found in smoke and vehicle exhaust, particularly focusing on how it can cause lung damage and cancer. The lab investigates how naphthalene is processed in the body, especially in the liver, and how these processes lead to toxic effects in the lungs. Their work aims to better understand the risk factors associated with exposure to this chemical and to find ways to monitor its effects on human health.

Dr. Melanie Maya Kaelberer's lab at the University of Arizona focuses on understanding how early-life dietary experiences shape lifelong food choices through a concept known as 'nutritional memory'. By examining gut cells that sense nutrients, the lab aims to discover how these cells influence our eating habits and overall metabolic health. The research could lead to innovative dietary guidelines and interventions, particularly for pregnant women and infants, to promote better health outcomes.

Dr. Abhijit A Date's lab at the University of Arizona focuses on developing more effective treatments for ocular herpes simplex virus infections, which are a major cause of blindness. The lab is particularly interested in repurposing an existing antiviral drug, adefovir dipivoxil, to create long-acting formulations that improve patient compliance. By using innovative strategies such as nanosuspensions, the lab aims to enhance how this medication is delivered to the eye, ensuring better outcomes for patients.